Nitric oxide based influence of nitrates on micturition in patients with benign prostatic hyperplasia

被引:48
作者
Klotz T. [1 ]
Mathers M.J. [3 ]
Bloch W. [2 ]
Nayal W. [2 ]
Engelmann U. [1 ]
机构
[1] Institute I of Anatomy, University of Cologne
[2] Urological Ambulatory, Remscheid
关键词
Nitric Oxide; Benign Prostatic Hyperplasia; Prostate Volume; Urinary Flow Rate; Smooth Muscle Relaxation;
D O I
10.1023/A:1007174102953
中图分类号
学科分类号
摘要
Background: Nitric oxide (NO) is involved in the physiologic regulation of smooth muscle relaxation in the prostate. Organic nitrates act as NO donors. In this prospective open study we prove the influence of orally given nitrates on micturition. Methods: Thirty-two patients underwent a urological medical check-up prior to starting nitrate medication for cardiovascular disease. We examined peak flow rates, residual urine, IPS-score, PSA level and prostate volume. Exact inclusion and exclusion criteria were defined. Fifteen patients suffered from obstructive symptoms, 17 patients reported no subjective micturition problems. Urological re-evaluation was performed two weeks and three months after nitrate medication. Results: A significant improvement of peak urinary flow rates (+3.1 ml/s; p<0.05), IPS score and significant decrease of residual urine volume (-22 ml; p<0.05) were found in the symptomatic patients. No significant changes of micturition parameters were found in asymptomatic patients. PSA levels and prostate volumes did not change in either groups. Conclusions: Organic nitrates influence micturition parameters in patients with obstructive benign prostatic hyperplasia. This might be explained by the known mechanism of NO donation (smooth muscle relaxation) of nitrates. More functional controlled studies are necessary to describe the grade of influence of nitrates on the prostate. Concomitant oral medication with nitrates must be considered as a relevant bias factor on BPH in future clinical studies.
引用
收藏
页码:335 / 341
页数:6
相关论文
共 22 条
[1]  
Burnett, A.L., Nitric oxide control of lower genitourinary tract functions: A review (1995) Urology, 45 (6), p. 1071
[2]  
Änggard, E., Nitric oxide: Mediator, murderer and medicine (1994) The Lancet, 343, p. 1199
[3]  
Moncada, S., Palmer, R.M.J., Higgs, E.A., Nitric oxide: Physiology, pathophysiology and pharmacology (1991) Pharmacol. Rev, 43, p. 109
[4]  
Ehren, I., Adolfsson, J., Wiklund, N.P., Nitric oxide synthase activity in the human urogenital tract (1994) Urol. Res., 22, p. 287
[5]  
Takeda, M., Tang, R., Shapiro, E., Burnett, A.L., Lepor, H., Effects of nitric oxide on human and canine prostates (1995) Urology, 45, p. 440
[6]  
Bloch, W., Klotz, T., Loch, C., Schmidt, G., Engelmann, U., Addicks, K., Distribution of nitric oxide synthase implies a regulation of circulation, smooth muscle tone and secretory function in the human prostate by nitric oxide (1997) The Prostate., 33
[7]  
Addicks, K., Bloch, W., Feelisch, M., Nitric oxide modulates sympathetic neurotransmission at the prejunctional level (1994) Microsc. Res Technique, 29, p. 161
[8]  
Garcia Moll, M., Principles and rules of the use of nitrates (1997) Ann. Cardiol. Angiol, 46 (7), p. 399
[9]  
Pörsti, I., Paakkari, I., Nitric oxide-based possibilities for pharmacotherapy (1995) Ann. Med., 27, p. 407
[10]  
Warren, J.B., Pons, F., Brady, A.J.B., Nitric oxide biology: Implications for cardiovascular therapeutics (1994) Cardiovasc. Res., 28, p. 25